These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Progesterone and medroxyprogesterone acetate effects on central and peripheral allopregnanolone and beta-endorphin levels. Bernardi F; Pluchino N; Pieri M; Begliuomini S; Lenzi E; Puccetti S; Casarosa E; Luisi M; Genazzani AR Neuroendocrinology; 2006; 83(5-6):348-59. PubMed ID: 16931878 [TBL] [Abstract][Full Text] [Related]
31. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group. Int J Fertil Menopausal Stud; 1993; 38(1):5-11. PubMed ID: 8485612 [TBL] [Abstract][Full Text] [Related]
32. Effects of either tibolone or continuous combined transdermal estradiol with medroxyprogesterone acetate on coagulatory factors and lipoprotein(a) in menopause. Perrone G; Capri O; Galoppi P; Brunelli R; Bevilacqua E; Ceci F; Ciarla MV; Strom R Gynecol Obstet Invest; 2009; 68(1):33-9. PubMed ID: 19349712 [TBL] [Abstract][Full Text] [Related]
33. [Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens]. Winkler UH; Krämer R; Kwee B; Schindler AE Zentralbl Gynakol; 1995; 117(10):540-8. PubMed ID: 7491837 [TBL] [Abstract][Full Text] [Related]
34. [Dihydrogesterone vs. medroxyprogesterone acetate in association with transdermal estradiol in postmenopausal substitution treatment]. Delzanno G; Paoletti R; Gaudiano L; Bertinetti G; Ventrella CA; Dell'Elce C Minerva Ginecol; 1994 Apr; 46(4):179-82. PubMed ID: 8065591 [TBL] [Abstract][Full Text] [Related]
35. Comparison of transdermal and oral sequential gestagen in combination with transdermal estradiol: effects on bleeding patterns and endometrial histology. Ross AH; Boyd ME; Colgan TJ; Ferenczy A; Fugere P; Lorrain J Obstet Gynecol; 1993 Nov; 82(5):773-9. PubMed ID: 8414325 [TBL] [Abstract][Full Text] [Related]
36. Sequential use of conjugated estrogens and medroxyprogesterone in the climacteric syndrome: clinical and histological findings. Figueroa-Casas PR; Schlaen I Maturitas; 1988 Mar; 9(4):309-13. PubMed ID: 2837619 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of a continuous estrogen-progestin regimen in the menopausal patient. Weinstein L Obstet Gynecol; 1987 Jun; 69(6):929-32. PubMed ID: 3574823 [TBL] [Abstract][Full Text] [Related]
38. A comparison of the central effects of different progestins used in hormone replacement therapy. Cagnacci A; Arangino S; Baldassari F; Alessandrini C; Landi S; Volpe A Maturitas; 2004 Aug; 48(4):456-62. PubMed ID: 15283939 [TBL] [Abstract][Full Text] [Related]
39. Hormone replacement therapy in menopausal women: Past problems and future possibilities. Schmidt JW; Wollner D; Curcio J; Riedlinger J; Kim LS Gynecol Endocrinol; 2006 Oct; 22(10):564-77. PubMed ID: 17135036 [TBL] [Abstract][Full Text] [Related]
40. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative. Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR; Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]